• Miltefosine: Dual Pathway Modulation in Leukopenia Research

  2026-07-20

  Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) is a bioactive small molecule that inhibits the PI3K/Akt pathway while activating Ras/MEK/ERK signaling, resulting in reduced cancer cell proliferation and enhanced neutrophil differentiation. Recent studies confirm its efficacy in both in vitro and in vivo leukopenia models, with well-characterized dosage and stability profiles.

• Forsythoside E–BSA Binding: Mechanistic Insights for PKM2 Re

  2026-07-19

  This study elucidates the distinct interaction between Forsythoside E and bovine serum albumin (BSA), revealing a unique fluorescence-enhancing, 1:1 binding mode. These mechanistic insights inform the pharmacokinetic interpretation and translational use of Forsythoside E as a pyruvate kinase M2 (PKM2) inhibitor and macrophage M2 polarization inducer.

• TAK-715 and the Dual-Action Revolution in p38α MAPK Inhibiti

  2026-07-18

  Explore how TAK-715, a next-generation p38 MAPK inhibitor from APExBIO, is redefining inflammation research by leveraging dual-action mechanisms to modulate kinase activity and accelerate phosphatase-driven dephosphorylation. This article offers mechanistic insights, protocol guidance, and translational perspectives for scientists seeking both precision and impact in cytokine signaling and rheumatoid arthritis studies.

• Epoxomicin: Benchmark Proteasome Inhibitor for Protein Degra

  2026-07-17

  Epoxomicin is a potent, selective, and irreversible proteasome inhibitor central to ubiquitin-proteasome pathway research. Its covalent action on the 20S proteasome enables precise protein degradation assays and advances the understanding of ER stress responses. APExBIO’s Epoxomicin (A2606) is widely adopted for modeling inflammation, bone regulation, and neurodegeneration.

• Single-Nucleus Profiling Reveals ATRNL1’s Role in Atrial Fib

  2026-07-17

  This study employs large-scale single-nucleus RNA sequencing to map cell-type specific transcriptional changes in atrial fibrillation, highlighting ATRNL1 overexpression in cardiomyocytes as a key factor in disease pathophysiology. The findings refine our understanding of the molecular mechanisms underlying AF and suggest new avenues for targeted therapy.

• VX-745 and the Dual-Action Future of p38α MAPK Inhibition

  2026-07-16

  VX-745 exemplifies a new era in kinase inhibitor research by leveraging a dual-action mechanism—simultaneously blocking p38α MAPK activity and promoting its dephosphorylation. This article unpacks mechanistic advances, translational strategies, and the evolving role of VX-745 in targeting inflammation, cancer, and aging, providing actionable insights for researchers navigating complex disease models and drug resistance.

• Gentamycin Sulfate: Applied Workflows in Resistance Research

  2026-07-16

  Gentamycin Sulfate from APExBIO stands out as a high-purity aminoglycoside antibiotic, enabling reproducible workflows for dissecting bacterial protein synthesis and antibiotic resistance. This article translates recent research breakthroughs and proven protocols into actionable guidance for laboratory scientists modeling Gram-negative infections and resistance mechanisms.

• IR-820 (New Indocyanine Green): Advancing In Vivo Tumor Imag

  2026-07-15

  IR-820 (New Indocyanine Green) empowers researchers to achieve precise, high-contrast vascular and tumor imaging using near-infrared fluorescence. Discover optimized protocols, troubleshooting strategies, and translational innovations that set this imaging agent apart for preclinical research.

• Caspase-4 Colorimetric Assay Kit: Quantitative Pyroptosis Re

  2026-07-15

  The Caspase-4 Colorimetric Assay Kit enables precise, rapid quantification of LEVD-dependent caspase-4 activity, serving as a benchmark tool for pyroptosis and inflammasome research. Its colorimetric readout at 405 nm ensures reproducibility across diverse experimental contexts.

• ZCL278: Selective Cdc42 Inhibitor for Cell Motility Suppress

  2026-07-14

  ZCL278, a selective Cdc42 inhibitor from APExBIO, enables researchers to precisely dissect cell motility, neuronal branching, and fibrosis signaling. This guide translates recent breakthroughs and practical workflows into actionable protocols and troubleshooting strategies for maximizing data integrity in advanced disease models.

• Chlorpromazine HCl: Mechanistic Bridges in Translational Res

  2026-07-14

  This article explores Chlorpromazine HCl as both a dopamine receptor antagonist and an emerging tool in host-directed antibacterial strategies. By integrating mechanistic and translational perspectives, we provide actionable guidance for researchers and highlight APExBIO’s product leadership.

• Precision Caspase Inhibition: Z-WEHD-FMK in Translational Re

  2026-07-13

  This article explores how Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) enables translational researchers to dissect caspase-driven inflammation and pyroptosis, with direct implications for infectious disease and oncology. By synthesizing recent mechanistic insights—such as the role of HOXC8-caspase-1 regulation in lung tumorigenesis—and providing actionable protocol guidance, we bridge experimental discovery with workflow optimization. This analysis advances the field beyond standard product literature, uniquely positioning Z-WEHD-FMK from APExBIO as an essential tool for next-generation caspase pathway research.

• Phalloidin (B7678): Technical Guidance for F-Actin Visualiza

  2026-07-13

  Phalloidin (SKU B7678) enables high-affinity, species-independent visualization and stabilization of filamentous actin (F-actin) in fixed or permeabilized samples. It is not suitable for live-cell imaging or studies requiring reversible actin dynamics, making it optimal for static cytoskeletal analyses where robust actin preservation is essential.

• DiR (DiIC 18 (7)) for Advanced Cell Membrane Staining Workfl

  2026-07-12

  DiR (DiIC 18 (7)) redefines long-term, high-sensitivity membrane imaging with exceptional near-infrared performance and minimal cytotoxicity. Unlock robust workflows for neuronal tracing, live cell tracking, and extracellular vesicle research using APExBIO’s trusted probe.

• AMPK’s Dual Role in Autophagy and Energy Stress Response

  2026-07-10

  This study redefines the role of AMPK in cellular energy stress, showing that AMPK suppresses autophagy initiation by inhibiting ULK1 rather than activating it. The findings have significant implications for energy metabolism and autophagy research, challenging longstanding models and refining experimental strategies.

454 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page